• 1
    Colombo C, Battezzati PM, Crosignani A, Morabito A, Constantini D, Padoan R, Giunta A. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology 2002; 36:13741382.
  • 2
    Lindblad A, Glaumann H, Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology 1999; 30:11511158.
  • 3
    Wilschanski M, Rivlin J, Cohen S, Augarten A, Blau H, Aviram M, Bentur L, et al. Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics 1999; 103:5257.
  • 4
    Kristidis P, Bozon D, Corey M, Markiewicz D, Rommens J, Tsui LC, Durie P. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992; 50:11781184.
  • 5
    Kappler MJ, Lang T, Harms HK, Bertele-Harms RM. Regular screening for serum liver enzymes and appropriate early therapy with ursodeoxycholic acid (UDCA) delays severe liver disease in CF [Abstract]. Pediatr Pulmonol 2001; 22(Suppl):340341.
  • 6
    Fuchs JR, Langer JC. Long-term outcome after neonatal meconium obstruction. Pediatrics 1998; 101:692693.
  • 7
    Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child 1991; 66:698701.
  • 8
    Feigelson J, Anagnostopoulos C, Poquet M, Pecau Y, Munck A, Navarro J. Liver cirrhosis in cystic fibrosis - therapeutic implications and long term follow up. Arch Dis Child 1993; 68:653657.
  • 9
    Feranchak AP, Sokol RJ. Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis 2001; 21:471488.
  • 10
    Kovesi T, Corey M, Tsui LC, Levison H, Durie P. The association between liver disease and mutations of the cystic fibrosis gene [Abstract]. Pediatr Pulmonol 1992; 8(Suppl):244.